Multidrug-Resistant Tuberculosis, People’s Republic of China, 2007–2009
Guang Xue He1 , Hai Ying Wang1, Martien W. Borgdorff, Dick van Soolingen, Marieke J. van der Werf, Zhi Min Liu, Xue Zheng Li, Hui Guo, Yan Lin Zhao, Jay K. Varma, Christopher P. Tostado, and Susan van den Hof
Author affiliations: Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China (G.X. He, H. Guo, Y.L. Zhao); University of Amsterdam, Amsterdam, the Netherlands (G.X. He, M.W. Borgdorff, M.J. van der Werf, S. van den Hof); Shandong Provincial Tuberculosis Control Center, Jinan, People’s Republic of China (H.Y. Wang, Z.M. Liu, X.Z. Li); National Institute for Public Health and the Environment, Bilthoven, the Netherlands (D. van Soolingen); KNCV Tuberculosis Foundation, The Hague, the Netherlands (M.J. van der Werf, S. van den Hof); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J.K. Varma); Tsinghua University, Beijing (C.P. Tostado)
Figure 2. Dendrogram of 100 multidrug-resistant tuberculosis cases analyzed by using the RD105 deletion test and the MIRU-VNTR method. RD, region of difference; MIRU-VNTR, mycobacterial interspersed repetitive unit–variable number of tandem repeats; B, Beijing family; NB, no Beijing family. Scale bar indicates nucleotide substitutions per site.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.